Allogeneic Stem Cell Transplantation Combined With Transfusion of Mesenchymal Stem Cells in Primary Myelofibrosis: A Multicenter Retrospective Study

Allogeneic Stem Cell Transplantation Combined With Transfusion of Mesenchymal Stem Cells in Primary Myelofibrosis: A Multicenter Retrospective Study

BackgroundAllogeneic stem cell transplantation (allo-SCT) remains the only effective curative therapy for primary myelofibrosis. Utilization and efficacy of allo-SCT are limited by lethal complications, including engraftment failure, and acute (aGVHD) and chronic graft-versus-host disease (cGVHD). S...

Full description

Bibliographic Details
Main Authors: Qingyuan Wang, Na Xu, Yu Wang, Xi Zhang, Limin Liu, Huifen Zhou, Hong Wang, Xiang Zhang, Xiaowen Tang, Chengcheng Fu, Miao Miao, Depei Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Oncology
Subjects:
primary myelofibrosis
allogeneic stem cell transplantation
mesenchymal stem cells
graft failure
overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.792142/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.792142/full

Similar Items